Get the Stockscreener App
5.655
10.02%
0.515
After Hours:
5.63
-0.025
-0.44%
Newcelx Ltd stock is traded at $5.655, with a volume of 424.89K.
It is up +10.02% in the last 24 hours and up +0.00% over the past month.
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
See More
Previous Close:
$5.14
Open:
$5.07
24h Volume:
424.89K
Relative Volume:
33.97
Market Cap:
$15.22M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$5.00
$6.48
1-Week Range:
$5.00
$6.48
52-Week Range:
$5.00
$6.48
Newcelx Ltd Stock (NCEL) Company Profile
Compare NCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NCEL
Newcelx Ltd
|
5.655 | 15.22M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Newcelx Ltd Stock (NCEL) Financials Data
There is no financial data for Newcelx Ltd (NCEL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Cap:
|
Volume (24h):